Watermark
  Back to Search Results

BGB-HNSCC-201

Completed

A Study of Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-HNSCC-201

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT05909904

EudraCT or EUCT Number Info icon SVG graphic used for tooltips or additional information.

2023

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20232123

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan